Cargando…
New insights into secondary prevention in post-traumatic stress disorder
Post-traumatic stress disorder (PTSD) is unique amongst psychiatric disorders in two ways. Firstly, there is usually a very clear point of onset- the traumatic event The second unique feature of PTSD is that it is characterized by a failure of the normal response to resolve. Given these two characte...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182005/ https://www.ncbi.nlm.nih.gov/pubmed/22033784 |
_version_ | 1782212858193379328 |
---|---|
author | Zohar, Joseph Juven-Wetzler, Alzbeta Sonnino, Rachel Cwikel-Hamzany, Shlomit Balaban, Evgenya Cohen, Hagit |
author_facet | Zohar, Joseph Juven-Wetzler, Alzbeta Sonnino, Rachel Cwikel-Hamzany, Shlomit Balaban, Evgenya Cohen, Hagit |
author_sort | Zohar, Joseph |
collection | PubMed |
description | Post-traumatic stress disorder (PTSD) is unique amongst psychiatric disorders in two ways. Firstly, there is usually a very clear point of onset- the traumatic event The second unique feature of PTSD is that it is characterized by a failure of the normal response to resolve. Given these two characteristics, PTSD appears a good candidate for secondary prevention, ie, interventions immediately after the trauma. Evidence available starting from current concepts and contemporary research of potential secondary prevention interventions are presented. Common practices in the aftermath of trauma such as debriefing and benzodiazepines need to be carefully considered, taking into account their potential harm to the spontaneous recovery process, and the trajectory of PTSD, and not only judging them according to their immediate (comforting) effects. A discussion of the balance required between aiding recovery but not interfering with the potent natural resolution of symptoms (that is expected in most cases), along with potential avenues of future research, are presented. Results of a small pilot study with a single intervention of hydrocortisone immediately after trauma appear to be promising, and clearly indicate the need for further studies. |
format | Online Article Text |
id | pubmed-3182005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Les Laboratoires Servier |
record_format | MEDLINE/PubMed |
spelling | pubmed-31820052011-10-27 New insights into secondary prevention in post-traumatic stress disorder Zohar, Joseph Juven-Wetzler, Alzbeta Sonnino, Rachel Cwikel-Hamzany, Shlomit Balaban, Evgenya Cohen, Hagit Dialogues Clin Neurosci Pharmacological Aspects Post-traumatic stress disorder (PTSD) is unique amongst psychiatric disorders in two ways. Firstly, there is usually a very clear point of onset- the traumatic event The second unique feature of PTSD is that it is characterized by a failure of the normal response to resolve. Given these two characteristics, PTSD appears a good candidate for secondary prevention, ie, interventions immediately after the trauma. Evidence available starting from current concepts and contemporary research of potential secondary prevention interventions are presented. Common practices in the aftermath of trauma such as debriefing and benzodiazepines need to be carefully considered, taking into account their potential harm to the spontaneous recovery process, and the trajectory of PTSD, and not only judging them according to their immediate (comforting) effects. A discussion of the balance required between aiding recovery but not interfering with the potent natural resolution of symptoms (that is expected in most cases), along with potential avenues of future research, are presented. Results of a small pilot study with a single intervention of hydrocortisone immediately after trauma appear to be promising, and clearly indicate the need for further studies. Les Laboratoires Servier 2011-09 /pmc/articles/PMC3182005/ /pubmed/22033784 Text en Copyright: © 2011 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Pharmacological Aspects Zohar, Joseph Juven-Wetzler, Alzbeta Sonnino, Rachel Cwikel-Hamzany, Shlomit Balaban, Evgenya Cohen, Hagit New insights into secondary prevention in post-traumatic stress disorder |
title | New insights into secondary prevention in post-traumatic stress disorder |
title_full | New insights into secondary prevention in post-traumatic stress disorder |
title_fullStr | New insights into secondary prevention in post-traumatic stress disorder |
title_full_unstemmed | New insights into secondary prevention in post-traumatic stress disorder |
title_short | New insights into secondary prevention in post-traumatic stress disorder |
title_sort | new insights into secondary prevention in post-traumatic stress disorder |
topic | Pharmacological Aspects |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182005/ https://www.ncbi.nlm.nih.gov/pubmed/22033784 |
work_keys_str_mv | AT zoharjoseph newinsightsintosecondarypreventioninposttraumaticstressdisorder AT juvenwetzleralzbeta newinsightsintosecondarypreventioninposttraumaticstressdisorder AT sonninorachel newinsightsintosecondarypreventioninposttraumaticstressdisorder AT cwikelhamzanyshlomit newinsightsintosecondarypreventioninposttraumaticstressdisorder AT balabanevgenya newinsightsintosecondarypreventioninposttraumaticstressdisorder AT cohenhagit newinsightsintosecondarypreventioninposttraumaticstressdisorder |